Riskpilot← Back to searchSign inGet full accessPCG PHARMACIES AS
ASActiveOrg 920936210Drotningsvikveien 132, 5179 GodvikRetail sale of pharmaceutical products · NACE 4773Est. 201815 employees
Revenue 2024
NOK 26,4M
+8% vs 2023
EBITDA margin
3.8%
-4% vs 2023
Equity ratio
19.1%
Financial strength
Net profit 2024
NOK 745K
+2% vs 2023
| Revenue | NOK 26,4M | +8% |
| EBITDA | NOK 994K | -4% |
| Net profit | NOK 745K | +2% |
| Total assets | NOK 5M | -28% |
| Equity | NOK 953K | +108% |
| Employees | 15 | — |
Legal name
PCG PHARMACIES AS
Org number
920936210
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2. juni 2018
Share capital
NOK 30 000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eierskap og drift av apotek, samt salg av farmasøytiske tjenester og alt som hører inn under dette, samt deltakelse i andre foretak med farmasirelatert virksomhet.
Address
Drotningsvikveien 132, 5179 Godvik
Email
solutions@pcgrx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 16 767 | 21 693 | 22 819 | 23 809 | 24 537 | 26 385 |
| Staff expenses | −0 | −3 466 | −3 590 | −3 902 | −3 943 | −4 045 | −4 480 |
| EBITDA | 0 | 587 | 1 321 | 1 178 | 1 306 | 1 034 | 994 |
| Depreciation & amort. | −0 | −162 | −159 | −152 | −138 | −25 | −17 |
| EBIT | 0 | 425 | 1 162 | 1 026 | 1 168 | 1 008 | 977 |
| Net financials | 0 | 0 | −0 | 0 | −1 | −10 | −20 |
| Profit before tax | 0 | 425 | 1 162 | 1 026 | 1 166 | 998 | 956 |
| Tax | −0 | 94 | 256 | 226 | 257 | 271 | 212 |
| Net profit | 0 | 331 | 906 | 800 | 909 | 727 | 745 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 30 | 4 287 | 4 782 | 4 759 | 5 569 | 6 982 | 4 997 |
| Equity | 18 | 419 | 245 | 655 | 578 | 459 | 953 |
| Long-term debt | 0 | 1 310 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 | 2 557 | 4 537 | 4 104 | 4 992 | 6 522 | 4 044 |
| Total debt | 12 | 3 867 | 4 537 | 4 104 | 4 992 | 6 522 | 4 044 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20182024
Equity ratio
19.1%
This company
38.2%
Market median
-50% vs market
20182024
Return on equity
78.1%
This company
18.4%
Market median
+324% vs market
20182024
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20182024
Asset turnover
5.28×
This company
1.12×
Market median
+371% vs market
20182024
Debt / equity
4.24×
This company
0.62×
Market median
-584% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IK Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Pesca Consulting Group As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pesca Consulting Group As
PCG PHARMACIES AS Board members of PCG PHARMACIES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingelill Kleivnes | Chief Executive Officer | 0 companies |
| Arne Aarhus | Board of Directors | 0 companies |